Optically Reversible News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optically reversible. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optically Reversible Today - Breaking & Trending Today

ILIAS Biologics Inc. Receives HREC Approval to Initiate First-in-Human Clinical Trial Evaluating Exosome Therapeutics ILB-202, the Treatment for CSA-AKI

/PRNewswire/ ILIAS Biologics Inc., a biotech company dedicated to developing a new treatment modality, engineered exosome therapeutics, announced today that. ....

Soult Ukpyolsi , South Korea , United States , Chulhee Choi , Biologics Inc , Kidney International , Kidney Injury Work Group , Human Research Ethics Committee , International Journal Of Nephrology , International Society Of Nephrology , Biomed Research International , Protein Loading , Optically Reversible , Neutrophil Gelatinase Associated Lipocalin , International Society , Acute Kidney Injury , Kidney Injury , Science Advance , Improving Global Outcomes , Acute Kidney Injury Work Group , Kidney Injury Treatment Market , Global Industry Analysis , Opportunity Assessment , Future Market Insights , Ilias Biologics ,

ILIAS Biologics announces the 2nd POC study, showing anti-inflammatory effects of ILB202 on preterm birth

Share this article
Share this article
DAEJEON, South Korea, Feb. 1, 2021 /PRNewswire/ ILIAS Biologics, Inc. announced that its latest research in collaboration with researchers at The University of Texas Medical Brand at Galveston (UTMB) is published in the journal
Science Advances(Link: https://advances.sciencemag.org/content/7/4/eabd3865). The study showed successful results in preventing preterm birth and improving the fetus viability with ILB-202, ILIAS s anti-inflammatory exosomes developed through its EXPLOR® platform technology.
This study result is the second proof of concept that suggests significant anti-inflammatory effects of the same exosome (ILB202) from ILIAS Biologics, Inc. In April 2020, the researchers at the Korea Advanced Institute of Science and Technology (KAIST) and the ILIAS team published the same exosome s substantial efficacy in the septic mouse model in ....

United States , Taejon Gwangyoksi , South Korea , Chulhee Choi , Ramkumar Menon , Biologics Inc , Department Of Obstetrics , World Health Organization , University Of Texas Medical Brand At Galveston , Korea Advanced Institute Of Science , Texas Medical Brand , Science Advances , Korea Advanced Institute , Protein Loading , Optically Reversible , Science Advance , Future Market Insights , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , ராம்குமார் மேனன் , உயிரியல் இன்க் , துறை ஆஃப் மகப்பேறியல் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ பிராண்ட் இல் கால்வெஸ்டன் , டெக்சாஸ் மருத்துவ பிராண்ட் , ப்ரோடீந் ஏற்றுகிறது ,

Treating 'fetus as the patient' could reduce the incidence of pre-term labor and premature birth

The results of a study by researchers at the University of Texas Medical Branch may pave the way for a new medicine delivery system that could reduce the incidence of pre-term labor and premature birth by allowing physicians to treat the 'fetus as the patient'. ....

South Korea , South Korean , Ramkumar Menon , Emily Henderson , Biologics Inc , Department Of Obstetrics , University Of Texas Medical Branch , Korea Advanced Institute Of Science , Texas Medical Branch , Cell Biology , Protein Loading , Optically Reversible , Korea Advanced Institute , Anti Inflammatory , Drug Delivery , Mouse Model , Premature Birth , தெற்கு கொரியா , தெற்கு கொரியன் , ராம்குமார் மேனன் , எமிலி ஹென்டர்சன் , உயிரியல் இன்க் , துறை ஆஃப் மகப்பேறியல் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை , டெக்சாஸ் மருத்துவ கிளை , செல் உயிரியல் ,

UTMB team proves potential for reducing pre-term birth by treating fetus as patient

E-Mail
GALVESTON, Texas - The results of a study by researchers at the University of Texas Medical Branch may pave the way for a new medicine delivery system that could reduce the incidence of pre-term labor and premature birth by allowing physicians to treat the fetus as the patient . The study has been published in
Science Advances.
It has long been suspected that pre-term labor is triggered by inflammation caused by a sick fetus. A new study by scientists at UTMB has proved the hypothesis by studying several important assumptions about the relationship between the health of a mother and her unborn child. ....

South Korea , Texas Medical Center , United States , University Of Texas , South Korean , Chulhee Choi , Samantha Sheller Miller , Young Eun Kim , Kyuna Kim , Ramkumar Menon , Enkhtuya Radnaa , Kyungson Choi , Jae Kwang Yoo , Eunsoo Kim , Lauren Richardson , Biologics Inc , Department Of Obstetrics , University Of Texas System , University Of Texas Medical Branch , Trauma Center , Office Of Marketing , Korea Advanced Institute Of Science , Texas Medical Branch , Cell Biology , Protein Loading , Optically Reversible ,